Bio-Techne
TECH
#1603
Rank
$10.01 B
Marketcap
$63.69
Share price
1.42%
Change (1 day)
-24.27%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of December 2023 : $1.96 B

According to Bio-Techne's latest financial reports the company has $1.96 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2023-06-30$1.96 B15.61%
2022-06-30$1.70 B8.26%
2021-06-30$1.57 B13.76%
2020-06-30$1.38 B18.5%
2019-06-30$1.16 B8.02%
2018-06-30$1.07 B13.63%
2017-06-30$0.94 B8%
2016-06-30$0.87 B3.82%
2015-06-30$0.84 B6.5%
2014-06-30$0.79 B7.83%
2013-06-30$0.73 B9.36%
2012-06-30$0.67 B15.07%
2011-06-30$0.58 B16.81%
2010-06-30$0.50 B9.93%
2009-06-30$0.45 B-6.29%
2008-06-30$0.48 B11.31%
2007-06-30$0.43 B28.59%
2006-06-30$0.34 B27.06%
2005-06-30$0.26 B-9.94%
2004-06-30$0.29 B25.7%
2003-06-30$0.23 B14.58%
2002-06-30$0.20 B16.24%
2001-06-30$0.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$46.84 B 2,285.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.33 B 1,190.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$28.58 B 1,355.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$53.49 B 2,624.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.80 B 93.92%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$70.77 M-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.74 B 345.17%๐Ÿ‡บ๐Ÿ‡ธ USA